divergent outcomes in pancreatic cancer trials at esmo gi 2024
Published 4 months ago • 230 plays • Length 0:25Download video MP4
Download video MP3
Similar videos
-
1:30
strategically planning clinical trials to improve outcomes in pancreatic cancer
-
1:56
predicting os with pfs in pancreatic cancer in the napoleon-1 and -2 trials
-
1:09
esmo gastrointestinal cancers congress 2024: submit your research
-
2:02
targeted therapies for personalized medicine in pancreatic cancer
-
2:00
advances in kras g12d-targeted therapy for pancreatic cancer
-
1:12
elucidating the optimal second-line therapy in metastatic pancreatic cancer
-
0:49
evaluating the future role of vegf inhibitors in pancreatic cancer
-
0:35
gastrointestinal cancer trials to watch out for in 2023
-
2:30
#esmo21 highlights on gemcitabine vs mfolfirinox in resected pancreatic cancer: prodige 24/cctg pa6
-
0:39
evaluating the role of adcs for biliary tract and pancreatic cancers
-
1:01
identifying pancreatic cancer treatment issues | osuccc – james
-
1:35
esmo gastrointestinal cancers congress 2024: why you should attend
-
20:33
colorectal cancer research highlights from esmo 2024
-
1:29
how much progress have we made in targeting kras in gi malignancies?
-
6:05
esmo 2024: upper gi cancer update
-
3:03
gap study: nab-paclitaxel & gemcitabine in locally advanced, unresectable pancreatic cancer
-
2:08
pancreatic cancer clinical trials nyc | weill cornell medicine gastrointestinal oncology program
-
1:23
destiny-pantumor02: trastuzumab deruxtecan in btc and pancreatic cancer